Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Note for evaluation of anticancer agents in man]

M Marty1, J P Bizarri

  • 1Service de Cancérologie, Hôpital Saint Louis, Paris, France.

Therapie
|July 1, 1997
PubMed
Summary

This document outlines clinical trial phases for anticancer drugs, focusing on determining maximum tolerated dose in Phase I, antitumour activity in Phase II, and comparative evaluation in Phase III for improved cancer treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Description and Durability of the Various Direct Restoration Techniques in Molar-Incisor Hypomineralization: A Systematic Review.

The European journal of prosthodontics and restorative dentistry·2025
Same author

Equimolar oxygen-nitrous oxide (EMONO) in dental pediatric care: which patients achieve therapeutic effects? A French national exploratory prospective observational multicenter study.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2024
Same author

Description and Durability of the Various Indirect Restoration Techniques in Molar-Incisor Hypomineralisation: A Systematic Review.

The European journal of prosthodontics and restorative dentistry·2023
Same author

Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023
Same author

Perception of Oral Health-Related Quality of Life in Children with Epidermolysis Bullosa: A Quantitative and Qualitative Study.

JDR clinical and translational research·2022
Same author

Toothbrushing in children with autism spectrum disorders: qualitative analysis of parental difficulties and solutions in France.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2021

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Context:

  • Guidance for clinical investigation of anticancer agents, particularly cytotoxic drugs.
  • Discussion of the Committee for Proprietary Medicinal Products (CPMP) note on clinical trial methodology.
  • Focus on Phase I, II, and III trial designs for anticancer drug development.

Purpose:

  • To define the objectives and methodologies for each phase of clinical trials for anticancer agents.
  • To establish standards for assessing drug toxicity, efficacy, and safety.
  • To propose recommendations for dose selection and patient population in clinical trials.

Summary:

  • Phase I trials determine the maximum tolerated dose (MTD) and characterize toxicity without requiring studies in normal volunteers.
  • Phase II trials investigate antitumour activity in specific patient populations, requiring clear definition and sufficient patient numbers.
  • Phase III trials are comparative, disease-oriented studies for full evaluation, establishing treatment regimens and assessing endpoints like survival rates.

Impact:

  • Provides a framework for designing robust clinical trials for novel anticancer therapies.
  • Aims to standardize the evaluation of anticancer agents, ensuring patient safety and treatment efficacy.
  • Contributes to the efficient development and approval of new cancer treatments through well-defined trial protocols.

Related Experiment Videos